Immunohistochemical studies of early breast cancer evolution (original) (raw)

Access this article

Log in via an institution

Subscribe and save

• Starting from 10 chapters or articles per month
• Access and download chapters and articles from more than 300k books and 2,500 journals
• Cancel anytime View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

1. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759–767, 1990.
   Google Scholar
2. O'Connell P, Pekkel V, Fuqua SAW, Osborne CK, Allred DC: Molecular genetic studies of early breast cancer evolution by LOH. Breast Cancer Res Treat (this issue).
3. Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR: Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 60:2751–2760, 1987.
   Google Scholar
4. Dupont WE, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146–151, 1985.
   Google Scholar
5. London SJ, Connolly JL, Schnitt SJ, Colditz GA: A prospective study of benign breast disease and the risk of breast cancer. J Am Med Assoc 267:941–944, 1992.
   Google Scholar
6. Palli D, Roselli del Turco M, Simoncini R, Bianchi S: Benign breast disease and breast cancer: A case-control study in a cohort in Italy. Int J Cancer 47: 703–706, 1991.
   Google Scholar
7. Kintanar EB, Raju U: Further delineation of patterns of atypical ductal hyperplasia: An analysis of ADH patterns associated with intraductal and invasive breast carcinoma. Mod Pathol 4:12A, 1991.
   Google Scholar
8. Alpers CE, Wellings SR: The prevalence of carcinoma in situ in normal and cancer-associated breasts. Human Pathol 16:796–807, 1985.
   Google Scholar
9. Jacquemier JD, Hassoun J, Torrente M, Martin PM: Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages — immunohistochemical study of 107 cases. Breast Cancer Res Treat 15:109–117, 1990.
   Google Scholar
10. Barnes R, Masood S: Potential value of hormone receptor assay in carcinoma in situ of breast. Am J Clin Pathol 94:533–537, 1990.
    Google Scholar
11. Poller DN, Snead DRJ, Roberts EC, et al: Oestrogen receptor expression in ductal carcinoma in-situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. Br J Cancer 68:156–161, 1993.
    Google Scholar
12. Meyer JS: Cell kinetics of histologic variants of in-situ breast carcinoma. Breast Cancer Res Treat 7:171–180, 1986.
    Google Scholar
13. Aasmundstad TA, Haugen OA: DNA ploidy in intraductal breast carcinomas. Eur J Cancer 26:956–959, 1990.
    Google Scholar
14. Killeen JL, Namiki H: DNA analysis of ductal carcinoma in situ of the breast. Cancer 68:2602–2607, 1991.
    Google Scholar
15. Gusterson BA, Machin LG, Gullick WJ, Gibbs NM, Powles TJ, Price P, McKinna A, Harrison S: Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer. Int J Cancer 42:842–845, 1988.
    Google Scholar
16. Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL: Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Human Pathol 23:974–979, 1992.
    Google Scholar
17. Gusterson BA, Machin LG, Gullick WJ, Gibbs NM, Powles TJ, Elliott C, Ashley S, Monaghan P, Harrison S: c-erbB-2 expression in benign and malignant breast disease. Br J Cancer 58:453–457, 1988.
    Google Scholar
18. Davidoff AM, Kerns BJM, Iglehart JC, Marks JR: Maintenance of p53 alterations throughout breast cancer progression. Cancer Res 51:2605–2610, 1991.
    Google Scholar
19. Poller DN, Roberts JA, Bell RA, Elston CW, Blamey RW, Ellis IO: p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Human Pathol 24:463–468, 1993.
    Google Scholar
20. Tsutsumi Y, Naber SP, DeLellis RA, et al: neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. Human Pathol 21:750–758, 1990.
    Google Scholar
21. Fromowitz FB, Viola MV, Chao S, et al: ras p21 expression in the progression of breast cancer. Hum Pathol 18:1268–1275, 1987.
    Google Scholar
22. Watson PH, Safneck JR, Le K, et al: Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 85:902–907, 1993.
    Google Scholar
23. Koukoulis GK, Virtanen I, Korhonen M, et al: Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Am J Pathol 139:787–799, 1991.
    Google Scholar
24. Smith HS, Lu W, Beng G, et al: Molecular aspects of early stages of breast cancer progression. J Cellular Biochem 176:144–152, 1993.
    Google Scholar

Download references